The bidding window for the AJC Jewel SME IPO was open from June 23, 2025, to June 26, 2025. The basis of allotment will be finalised today, June 27, 2025. Here’s how you can check the IPO allotment status.
AJC Jewel IPO is a book-building issue of ₹15.39 crores, consisting entirely of a fresh issue of 16.20 lakh equity shares. The price band is set at ₹90 to ₹95 per share. The tentative listing on BSE is July 1, 2025.
Smart Horizon Capital Advisors Private Limited is the book-running lead manager, and Bigshare Services Pvt Ltd is the registrar for the issue.
Click here to explore other Upcoming IPOs
The net proceeds from the fresh issue will be used towards:
(June 26, 2025, end of the day)
Category |
Subscription (times) |
Qualified Institutional Investors (QIBs) |
3.57 |
Non-Institutional Investors |
1.79 |
Retail Individual Investors(RIIs) |
2.86 |
Total |
2.82 |
Click here to check out newly Listed IPOs
As of 27 June 2025, AJC Jewel IPO GMP stood at ₹4. The expected listing price is ₹99, i.e., a 4.21% gain per share over the upper price band.
Source: Business Standard Report dated 27 June, 2025 Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market. |
AJC Jewel manufactures and designs a wide range of wholesale Gold jewellery, including plain gold, studded and named pieces in 22karat and 18Karat from raw gold. The company then sells it to dealers, showrooms, corporates and small jewellery shops in wholesale quantities.
On the financial front, AJC’s revenue from operations increased to ₹24,588.99 Lakhs in Fiscal 2024 from ₹19,418.14 Lakhs in Fiscal 2023 at a CAGR of 26.63%.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here